Importantly, although we did not found stronger anti-tumor effects of anti-CD25 treatment alone than that of SLC treatment alone in our preliminary experiments (data not shown), in the present study we found anti-CD25 mAbs treatment greatly boosted the anti-tumor effects of SLC, proving the efficacy of the combination therapy. This evidence concerns the gene CCL21 and neoplasm.